| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | We are a biopharmaceutical company focused on reducing the manufacturing costs of (biosimilars of) Monoclonal Antibody (mAbs) biological drugs, in order to increase patient access to this important family of therapeutics. We have developed technology capable of reducing the COGS more than 10-fold, which allows healthy profitability even at 50% of the pricing of originator drugs. |
| Category: | Health & biotech |
| URL: | http://www.biosanapharma.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | |
| State: | Victoria, Western Australia |
| Overseas Operations: | No |
| Twitter: | |
| Facebook: | |
| Linkedin: | |
| Founders: |
No items found
|
| Awards won: | |
